You are here

Home

Vertex Pharmaceuticals Inc.

Company Information
Address
40 Allston St
Cambridge, MA 02139
United States
Information

UEI: N/A

# of Employees: 54
Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No

Award Charts




Award Listing

  • Record 1 TO 7

  1. CROSSLINKED ENZYME CRYSTALS AS CATALYSTS IN ORGANIC SYNTHESIS

    Amount: $300,000.00

    ENZYME CATALYZED PROCESSES OFFER SIGNIFICANT ADVANTAGES OVERTRADITIONAL CHEMICAL METHODS IN ORGANIC SYNTHESES, INCLUDINGSUPERIOR EFFICIENCY, STEREOSELECTIVITY AND SPECIFICITY. HOWEVER, SOLUBLE AND CON ...

    SBIRPhase II1993National Science Foundation

  2. HUMAN CDNA/GENE FOR AN IMMUNOSUPPRESSANT-BINDING PROTEIN

    Amount: $500,000.00

    THIS PHASE I PROJECT WILL CONDUCT EXPERIMENTS TO INITIATE MOLECULAR ANALYSIS OF THE HUMAN CDNA AND GENE ENCODING FK-506 BINDING PROTEIN (FK-506 BP), A CYTOSOLIC PROTEIN THATBINDS THE POTENT IMMUNOSUPP ...

    SBIRPhase II1992Department of Health and Human Services

  3. NON-VIRAL, HUMAN T CELL ASSAY FOR HIV-1 PROTEASE

    Amount: $50,000.00

    ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) IS AN ENORMOUS HEALTH THREAT. THE CAUSATIVE AGENT ON AIDS IS THE HIV-1 VIRUS. CONSEQUENTLY, THERE IS AN ONGOING EFFORT TOWARDS IDENTIFYING NOVEL ANTI-HIV-1 T ...

    SBIRPhase I1992Department of Health and Human Services

  4. CROSSLINKED ENZYME CRYSTALS AS CATALYSTS IN ORGANIC SYNTHESIS

    Amount: $49,556.00

    N/A

    SBIRPhase I1992National Science Foundation

  5. NOVEL ENZYME IMMOBILIZATION FOR BIOSENSOR APPLICATIONS (BACTERIA)

    Amount: $49,825.00

    ENZYME CRYSTALS, CROSS-LINKED USING A BIFUNCTIONAL REAGENT SUCH AS GLUTARALDEHYDE, CONSTITUTE A NOVEL FORM OF ENZYME IMMOBILIZATION. SUCH CROSS-LINKED IMMOBILIZED ENZYME CRYSTALS (CLIECS) ARE SUPERIOR ...

    SBIRPhase I1991Department of Health and Human Services

  6. SUBSTRATES FOR PEPTIDYL PROLYL CIS-TRANS ISOMERASE ASSAYS

    Amount: $50,000.00

    RECENT REPORTS HAVE INDICATED THAT FK-506, A NOVEL, HIGHLY POTENT IMMUNOSUPPRESSANT, IS AN EFFECTIVE AGENT FOR PREVENTING ORGAN TRANSPLANT REJECTION IN HUMANS THAT DISPLAYS A DIFFERENT TOXICITY PROFIL ...

    SBIRPhase I1990Department of Health and Human Services

  7. HUMAN CDNA/GENE FOR AN IMMUNOSUPPRESSANT-BINDING PROTEIN

    Amount: $49,955.00

    N/A

    SBIRPhase I1990Department of Health and Human Services
US Flag An Official Website of the United States Government